| Abstrakt: |
Background: It is still debatable how congenital melanocityc nevi (CMN) should be treated. Among the treatment options are chemical peeling, partial-thickness and full-thickness excisions of the lesions, dermabrasion, curettage, and laser therapy. Any of the aforementioned methods will lessen the total number of melanocytes; however, the results are usually unsatisfactory. The authors of this study set out to assess the effectiveness of cryocarboxy surgery in the treatment of CMN types II, III, and I. They looked at the histopathological alterations brought on by the use of this therapeutic approach in various forms of CMN. Methods: Between January 2012 and April 2021, 292 patients with CMNs of various sizes participated in this study. There are three different types of congenital melanocytic nevi. Among the patients' CMN were 169 as type I (non-hairy), 84 as type II (hairy), and 39 as type III (hypertrophic type). All cases with CMN described in this study were treated with cryocarboxy surgery. In every instance, carbon dioxide has been utilized as the cryogen. Results: Clinical assessment showed excellent results in 185 (63.4%) patients, good results in 91 (31.2%) patients, and fair results in 16 (5.4%) patients, and no poor results were reported. Conclusions: Congenital melanocytic nevi of various forms, patients with diverse skin types, and CMNs of various colors, all can be treated with cryocarboxy surgery safely. Cryocarboxy surgery stays away from all the problems with conventional surgery. Level of evidence: Level IV, therapeutic study. [ABSTRACT FROM AUTHOR] |
Full text from SpringerLink